A dietary antioxidant, alpha-tocopherol, will be used to potentially attenuate Vitamin E short- and long-term losses in plasma and adipose, reverse the oxidative stress of burn injury and, in the process, decrease the secondary consequences of burn injury, including lung injury and impaired wound healing. This may improve the quality of life of the burn patient by preventing pathophysiology that may result from oxidative stress and may reduce hospital stay. Our research will lay the foundation for the future development of effective, safe, and economic therapeutic interventions to treat burn injury-associated metabolic abnormalities. Also, it will provide the basis for the development of supplemental regulations and pharmacotherapy to treat burn patients with vitamin E. The risks are very reasonable in relation to the anticipated benefits to our subjects because a) vitamin E is a simple vitamin that is abundant and approved for clinical use, and b) the subjects will be monitored consistently for the minimal increased tendency to bleed.
Please see above.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Enrollment
27
1200 IU dl-alpha tocopheryl acetate after the initial excision surgery after admission (days 1-15 or days 16-30)
University of Texas Southwestern Medical Center, Parkland Health and Hospital System
Dallas, Texas, United States
University of Texas Medical Branch: Blocker Burn Unit and Shriners Hospitals for Children
Galveston, Texas, United States
Memorial Hermann Hospital Burn Intensive Care Unit
Houston, Texas, United States
Number of Participants Assessed for Plasma Alpha- and Gamma-Tocopherol Levels
Number of participants who had plasma alpha- and gamma-tocopherol levels measured during the study.
Time frame: Days 0-30
Number of Participants Completing Pulmonary Function Testing
Number of participants who completed pulmonary function testing during the study period.
Time frame: Day 30
Number of Participants Assessed for Plasma and Urine Oxidative Stress and Vitamin E Metabolite Biomarkers
Number of participants with plasma and urine malondialdehyde, isoprostanes, and Vitamin E metabolites measured during the study.
Time frame: Days 0-30
Number of Participants Assessed for Adipose Alpha- and Gamma-Tocopherol Concentrations
Number of participants with adipose tissue alpha- and gamma-tocopherol concentrations evaluated during the study.
Time frame: Days 0-30
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.